SCOPUS 정보 검색 플랫폼

Nature Reviews Neurology

Volumn 7, Issue 11, 2011, Pages 600-602

Parkinson disease: Is GDNF beneficial in Parkinson disease?

(2) Hoffer, Barry J a Harvey, Brandon K a

a NATIONAL INSTITUTE ON DRUG ABUSE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; LENTIVIRUS VECTOR; MESSENGER RNA; PARVOVIRUS VECTOR; PROTEIN RET;

ALPHA SYNUCLEIN GENE; ARTICLE; CELL STRESS; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1 GENE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN HOMEOSTASIS; RET GENE; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM;

EID: 80755138382 PISSN: 17594758 EISSN: 17594766 Source Type: Journal
DOI: 10.1038/nrneurol.2011.149 Document Type: Article

Times cited : (18)

References (10)

1
- 66149096521
- Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys
- Eberling, J. L. et al. Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys. Hum. Gene Ther. 20, 511-518 (2009).
- (2009) Hum. Gene Ther. , vol.20 , pp. 511-518
- Eberling, J.L.¹

2
- 80051985178
- GDNF fails to exert neuroprotection in a rat α-synuclein model of parkinsons disease
- Decressac, M. et al. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease. Brain 134, 2302-2311 (2011).
- (2011) Brain , vol.134 , pp. 2302-2311
- Decressac, M.¹

3
- 0032850453
- Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease
- DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q
- Kordower, J. H. et al. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. Neurol. 46, 419-424 (1999). (Pubitemid 29416283)
- (1999) Annals of Neurology , vol.46 , Issue.3 , pp. 419-424
- Kordower, J.H.¹ Palfi, S.² Chen, E.-Y.³ Ma, S.Y.⁴ Sendera, T.⁵ Cochran, E.J.⁶ Mufson, E.J.⁷ Penn, R.⁸ Goetz, C.G.⁹ Comella, C.D.¹⁰

4
- 0038249170
- Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
- DOI 10.1038/nm850
- Gill, S. S. et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595 (2003). (Pubitemid 36597106)
- (2003) Nature Medicine , vol.9 , Issue.5 , pp. 589-595
- Gill, S.S.¹ Patel, N.K.² Hotton, G.R.³ O'Sullivan, K.⁴ McCarter, R.⁵ Bunnage, M.⁶ Brooks, D.J.⁷ Svendsen, C.N.⁸ Heywood, P.⁹

5
- 33644833272
- Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
- DOI 10.1002/ana.20737
- Lang, A. E. et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59, 459-466 (2006). (Pubitemid 43358066)
- (2006) Annals of Neurology , vol.59 , Issue.3 , pp. 459-466
- Lang, A.E.¹ Gill, S.² Patel, N.K.³ Lozano, A.⁴ Nutt, J.G.⁵ Penn, R.⁶ Brooks, D.J.⁷ Hotton, G.⁸ Moro, E.⁹ Heywood, P.¹⁰ Brodsky, M.A.¹¹ Burchiel, K.¹² Kelly, P.¹³ Dalvi, A.¹⁴ Scott, B.¹⁵ Stacy, M.¹⁶ Turner, D.¹⁷ Wooten, V.G.F.¹⁸ Elias, W.J.¹⁹ Laws, E.R.²⁰ more..

6
- 0029007011
- Peripheral expression and biological activities of GDNF a new neurotrophic factor for avian and mammalian peripheral neurons
- Trupp, M. et al. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137-148 (1995).
- (1995) J. Cell Biol. , vol.130 , pp. 137-148
- Trupp, M.¹

7
- 0028898505
- Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo
- Hudson, J. et al. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425-432 (1995).
- (1995) Brain Res. Bull. , vol.36 , pp. 425-432
- Hudson, J.¹

8
- 0032507692
- Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease
- DOI 10.1016/S0006-8993(98)00131-0, PII S0006899398001310
- Walker, D. G. et al. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease. Brain Res. 792, 207-217 (1998). (Pubitemid 28267533)
- (1998) Brain Research , vol.792 , Issue.2 , pp. 207-217
- Walker, D.G.¹ Beach, T.G.² Xu, R.³ Lile, J.⁴ Beck, K.D.⁵ McGeer, E.G.⁶ L. McGeer, P.⁷

9
- 33745215642
- Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinsons disease: A real-time PCR study
- Bäckman, C. M. et al. Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study. Mol. Cell. Endocrinol. 252, 160-166 (2006).
- (2006) Mol. Cell. Endocrinol. , vol.252 , pp. 160-166
- Bäckman, C.M.¹

10
- 79551647443
- Induction of the unfolded protein response by α-synuclein in experimental models of Parkinsons disease
- Bellucci, A. et al. Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. J. Neurochem. 116, 588-605 (2011).
- (2011) J. Neurochem. , vol.116 , pp. 588-605
- Bellucci, A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.